SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-005278
Filing Date
2021-11-17
Accepted
2021-11-17 20:01:22
Documents
1
Period of Report
2021-11-15

Document Format Files

Seq Description Document Type Size
1 form4-11172021_051141.html 4  
1 form4-11172021_051141.xml 4 12606
  Complete submission text file 0001415889-21-005278.txt   14000
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 1LIFE HEALTHCARE, INC. ONE EMBARCADERO CENTER, SUITE 1900 SAN FRANCISCO CA 94111
Business Address
Blumenkranz Mark S. (Reporting) CIK: 0001614869 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 211422239